OS Therapies Incorporated (OSTX) Live Share Price, Invest From India

OS Therapies Incorporated Stock Performance

as on October 3, 2026 at 2:16 pm IST

Day's High
$1.62
Day's Price Range
$1.66
$1.62
2.47%
Upside
52 Week's Low
52 Week's High
$1.15
52-Week Price Range
$2.25
$1.62
29.01%
Downside
38.89%
Upside

OS Therapies Incorporated share price movements today

Previous Close: $1.61
Open: $1.62
Volume: 413.1K
Market Cap: $75.4M
Day's Low - High: $1.62 - $1.66
52 Week Low - High: $1.15 - $2.25

OS Therapies Incorporated Historical Returns

1 Month Return: -10.99 %
3 Month Return: -14.29 %
1 Year Return: -19.8 %
3 Year Return: 0 %
5 Year Return: 0 %

OS Therapies Incorporated Stock Fundamentals & Key Indicators

Check OS Therapies Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$75.4M

EPS (TTM)

-1.09

Dividend Yield

0.00%

PE Ratio (TTM)

-1.49

Industry PE ratio

-3.02

PEG Ratio

0.02

Return On Equity TTM

683.03%

OS Therapies Incorporated vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OS Therapies Incorporated with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
OS Therapies Incorporated	Buy	$75.4M	NA	-1.49	0.00%	0.00%
Revolution Medicines	StrongBuy	$44.1B	609.62%	-23.34	0.00%	0.00%
Moderna	Neutral	$75.4B	-44.29%	-24.08	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.5B	180.98%	30.19	86.04%	0.00%
Regeneron	Buy	$78.1B	28.80%	17.67	84.86%	0.50%

Stock Returns calculator for OS Therapies Incorporated Stock including INR - Dollar returns

The OS Therapies Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

OS Therapies Incorporated investment value today

Current value as on today

₹87,035

Returns

-₹12,965

(-12.96%)

Returns from OS Therapies Incorporated Stock

-₹19,802 (-19.8%)

Dollar Impact

₹6,837 (+6.84%)

Analyst Recommendation on OS Therapies Incorporated Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for OS Therapies Incorporated. Average target price of $7

Indian Investors' Interest in OS Therapies Incorporated Stock

Search interest for OS Therapies Incorporated Stock has increased by 70% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 4, 2026 to October 4, 2026

Change:70% versus previous 30 day period

OS Therapies Incorporated Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	0	0	-	-	0	-	0	0
Operating Income	0	-1	0	0	-2	-4	-4	-6	-10	-8
EBITDA	0	0	0	0	-2	-3	-4	-6	-10	-8
Interest Expense	1	0	0	0	0	-	-	-	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	-1	-2	-3	-4	-6	-10	-8
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-1	-2	-3	-4	-6	-10	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OS Therapies Incorporated Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Mar 2026
Total Revenue	-	-	-	-	-	-
Gross Profit	0	-1	0	0	0	0
Operating Income	0	-4	-4	-4	-6	-28
EBITDA	0	-4	-4	-4	-6	-28
Interest Expense	461	2	1	3	2	-
Depreciation	0	0	0	0	0	0
Income Before Tax	0	-7	-6	-7	-8	-28
Income Tax Expense	-	-	-	-	-	-
Net Income	0	-7	-6	-7	-8	-28
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OS Therapies Incorporated Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Net Income	-1	-1	-1	-1	-2,875	-3	-4	-6	-10	-8
Operating Cash Flow	0	0	0	0	-3,384	-3	-2	-4	-4	-5
Investing Cash Flow	-	0	-	-	-	0	0	-	-	-
Financing Cash Flow	0	0	0	0	5,147	1	2	3	5	4
Change in Cash	0	0	0	0	1,763	-2	0	0	0	0

OS Therapies Incorporated Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Mar 2026
Net Income	-6,027	-7	-6	-7	-8	-28,753
Operating Cash Flow	-2,413	-4	-3	-3	-7	-14,238
Investing Cash Flow	158	0	0	0	-	-466
Financing Cash Flow	3,477	3	3	2	12	9,441
Change in Cash	1,232	-1	0	0	5	-5,263

Global Institutional Holdings in OS Therapies Incorporated

Check out the Institutions with significant holdings in OS Therapies Incorporated.

Funds	Holdings
Vanguard	1.66%
VANGUARD INDEX FUNDS	0.86%
Fidelity Concord Street Trust	0.41%
iShares	0.24%
VANGUARD INSTITUTIONAL INDEX FUNDS	0.14%

See all

Insights on OS Therapies Incorporated

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 586.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, OSTX stock has moved down by -13.8%

About OS Therapies Incorporated

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.

Organisation	OS Therapies Incorporated
Headquarters	115 Pullman Crossing Road, Grasonville, MD, 21638, US
Industry	Biotechnology
CEO	Paul A. Romness

Key Management of OS Therapies Incorporated

Name	Title
Mr. Paul A. Romness M.P.H.	Founder, Chairman, President & CEO
Mr. Christopher P. Acevedo	Chief Financial Officer
Dr. Robert G. Petit II, Ph.D.	Chief Medical Officer & Chief Scientific Officer
Mr. Jack Doll	Chief of Staff
Mr. Gerald E. Commissiong	Chief Business Officer

FAQs

What is OS Therapies Incorporated share price today?

OS Therapies Incorporated share price today is $1.62 as on October 3, 2026 at 8:46 am IST at the close of the market. OS Therapies Incorporated share today touched a day high of $1.66 and a low of $1.62.

What is the 52 week high and 52 week low for OS Therapies Incorporated share?

OS Therapies Incorporated share touched a 52 week high of $2.25 on June 29, 2026 and a 52 week low of $1.15 on February 19, 2026. OS Therapies Incorporated stock price today i.e. October 3, 2026 at 8:46 am IST is closed at $1.62,which is 28.00% down from its 52 week high and 40.87% up from its 52 week low.

What is OS Therapies Incorporated's market capitalisation today?

OS Therapies Incorporated market capitalisation is $0.00T as on October 3, 2026 at 8:46 am IST.

How to invest in OS Therapies Incorporated Stock (OSTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for OS Therapies Incorporated on INDmoney app. Click on Buy button.

What is the minimum amount required to buy OS Therapies Incorporated Stock (OSTX) from India?

Indian investors can start investing in OS Therapies Incorporated (OSTX) shares with as little as ₹96.300003051758 or $1 (as of October 4, 2026 at 10:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in OS Therapies Incorporated stock (as per the Rupee-Dollar exchange rate as on October 4, 2026 at 10:38 am IST). Based on OS Therapies Incorporated share’s latest price of $1.62 as on October 3, 2026 at 8:46 am IST, you will get 6.1728 shares of OS Therapies Incorporated. Learn more about fractional shares .